The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Dosing & titration

How the published trials escalated, tabulated side by side — does this still hold?

Solved
Solved by ew.kuusela in post #2
Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you stay at an intermediate dose for years is not formally studied and extrapolation is the best available reasoning.

Jump to the accepted answer →

MA
mi.almeidaTL21 Jan 2025#1

Asking directly, because I could not find a straight answer: How the published trials escalated, tabulated side by side — does this still hold?

Asking about published trials escalated directly, because I have read four threads on it and each answered a slightly different question.

The version I want answered is the narrow one: given the method stated below, is the result within what anyone else has seen? I am not asking what it means yet.

Method, numbers and the two assumptions I am aware of making are below. If the assumptions are wrong that is more useful to me than agreement.

11 likes 19mo
EK
ew.kuuselaTL2 Solution24 Jun 2025#2

Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you stay at an intermediate dose for years is not formally studied and extrapolation is the best available reasoning.

15 likes 13mo
SS
s.stavrianosTL2Member28 Oct 2025 · edited#3
mi.almeida, post #1: Asking directly, because I could not find a straight answer: How the published trials escalated, tabulated side by side — does this still hold? Asking about published trials escalated directly, because I have read four threads on it and each answered a slightly different question. The version I want answered is the narrow one: given the… Go to post

Narrowing post #2, because the general version has more than one answer.

Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by real-world reports. The dose does not seem to stop working, but the longest trials are not indefinitely long.

Adding it because I spent an afternoon working it out and nobody should have to twice.

30 likes in reply to #1 9mo

Suggested topics

TopicParticipantsRepliesViewsActivity
How the published trials escalated, tabulated side by side
The question in the title: How the published trials escalated, tabulated side by side I will give what I have already checked below so nobody repeats it. Something about published trials escalated does not…
ASCTGAOFCC+4 8 4.2k 5mo
Where the four-week escalation interval comes from, and what it is not
On the subject in the title: Where the four-week escalation interval comes from, and what it is not Working notes rather than a conclusion. Working notes on four-week escalation interval rather than a…
CCNWVNRW+56 60 21k 2y
Micro-titration: a disputed topic, argued properly — one year on
Posting this under the heading it deserves: Micro-titration: a disputed topic, argued properly — one year on Everything below is what sits behind that. Reading back through what has been written here about…
NSKRSICPAC+63 68 35k 1d
[2026 update] Dose numbers across compounds are not on the same scale
On the subject in the title: Dose numbers across compounds are not on the same scale Working notes rather than a conclusion. A narrow question about Dose numbers across compounds, deliberately narrow, because…
KVBVHDITNL+14 18 1.2k 13mo
Revisiting: The arithmetic of an intermediate dose between two label steps
Revisiting: The arithmetic of an intermediate dose between two label steps Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
CSRHGBWTMR+41 45 808 2mo

Related topics — sharing the tags dose reduction, tirzepatide, missed dose

TopicParticipantsRepliesViewsActivity
[2026 update] Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA — setting out what I have, and where I think it stops being reliable. Reading back through what has been written here about Tirzepatide in…
TTSIKR 2 58k 11mo
Needle changes between doses on a reusable pen
Posting this under the heading it deserves: Needle changes between doses on a reusable pen Everything below is what sits behind that. The question about needle changes between doses that I actually want…
KMKKLSKAW+34 38 1.5k 10mo
Cold solution and stinging: the simplest fix
Posting this under the heading it deserves: Cold solution and stinging: the simplest fix Everything below is what sits behind that. An honest uncertainty about cold solution and stinging rather than a…
ATJRCTDBTD+35 39 8.2k 30d
Revisiting: Holding a dose indefinitely: is there a documented downside?
The question in the title: Revisiting: Holding a dose indefinitely: is there a documented downside? I will give what I have already checked below so nobody repeats it. I have read the maintained page on this…
MVBVPKCC+26 30 4.5k 18mo
Pinch or no pinch, and how needle length changes the answer — what changed since
Posting this under the heading it deserves: Pinch or no pinch, and how needle length changes the answer — what changed since Everything below is what sits behind that. What changes if the standard account of…
GRSSSVNEHA+58 62 16k 1d